Evaluation of interleukin-7 and lipid profile in breast cancer women

Maher Hatem Abbas; Abdulsalam Tawfeeq Salih Alsamarai

doi:10.53730/ijhs.v6nS3.7417

Authors

Maher Hatem Abbas
maheralzede697@gmail.com
Diyala Education Directorate, Al Salam School for Boys
Abdulsalam Tawfeeq Salih Alsamarai University of Samarra, College of Applied Sciences, Applied Chemistry Department

Keywords:

breast cancer, interleukin-7, lipid profile, Cholesterol, lipoprotein

Abstract

Breast cancer is one of the most common cancerous tumors and one of the main causes after lung cancer that leads to death, and the most common type of breast cancer is adenocarcinoma and is usually detected either during the examination before symptoms appear or after the woman notices the presence of the tumor. Breast cancer is one of the most common diseases in Iraq recently. This study was designed to measure the level of interleukin-7 and its role in cancer, as well as to find out the Level of lipids (cholesterol, triglycerides, and high-density lipoproteins) in breast cancer women and compare them with the control group. The results showed a significant increase( P≤ 0.05) in the level of interleukin-7and high-density lipoprotein cholesterol (357.505±89.921µg\L, 104.383±20.865mg\dl) respectively among patients with breast cancer compared with the control group (150.705±39.559µg\L,114.782±14.139mg\dl) respectively, , and the results showed a significant decrease ( P≤ 0.05) in the level of cholesterol a and triglycerides in patients with breast cancer (104.383±20.865mg\dl , 110.388±18.180mg\dl) respectively compared with the control group(114.782±14.139mg\dl, 138.925±23.178mg\dl) respectively.

Downloads

Download data is not yet available.

References

Hamid, A .A . (2010) .The sidelines of effectiveness: The Cancer Council and the High Commissionfor fight against breast cancer in the Ministry of Health on the occasion of the month challenge of breast cancer.

Hashim, B. H., Abed, K. K., Tareq, L. Z., &Ra’id, A. (2018). Evaluation of risk factors in Breast Cancer among Iraqi female patients. World Journal of Pharmaceutical Research, (7), 46-55.‏

Schummer, M., Beatty, D., & Urban, N. (2010). Breast cancer genomics: normal tissue and cancer markers. Annals of the New York Academy of Sciences, 1210(1), 78-85.‏

Carr, J. A., Havstad, S., Zarbo, R. J., Divine, G., Mackowiak, P., &Velanovich, V. (2000). The association of HER-2/neu amplification with breast cancer recurrence. Archives of Surgery, 135(12), 1469-1474.‏

Florescu, A., Amir, E., Bouganim, N., & Clemons, M. (2011). Immune therapy for breast cancer in 2010—hype or hope?. Current oncology, 18(1), 623.‏

uchholz, T. A. (2009). Radiation therapy for early-stage breast cancer after breast-conserving surgery. New England Journal of Medicine, 360(1), 63-70.

Chlebowski, R. T., Kuller, L. H., Prentice, R. L., Stefanick, M. L., Manson, J. E., Gass, M., ...& Anderson, G. (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. New England journal of medicine, 360(6), 573-587.‏

Saini, K. S., Taylor, C., Ramirez, A. J., Palmieri, C., Gunnarsson, U., Schmoll, H. J., ...& De Azambuja, E. (2012). Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Annals of oncology, 23(4), 853-859.‏

Barata JT, Durum SK, Seddon B. Flip the Coin: IL-7 and IL-7R in Health and Disease. Nat Immunol (2019) 20(12):1584–93. doi: 10.1038/s41590-019-0479-x.

Alpdogan O, van den Brink MR. IL-7 and IL-15: Therapeutic Cytokines for Immunodeficiency. Trends Immunol (2005) 26(1):56–64. doi: 10.1016/j.it.2004.11.002.

Ingley E, Klinken SP. Cross-Regulation of JAK and Src Kinases. Growth Factors (2006) 24(1):89–95. doi: 10.1080/08977190500368031.

BOESCH, Maximilian, et al. Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. Oncoimmunology, 2018, 7.4: e141412

a. Tietz,N. W. (1999). Textbook of clinical chemistry. 3rded. C.A.Burtis, E.R.Ashwood,W.B.Saunders. pp: 819-861,1245-1250.

b. Burtis,C. A. and Ashwood,E. R. (1999). Teitz Text Book of Clinical Chemistry, 3rded.,W.B.SaundersCompany,London,UK., pp: 840-843.

Friedewald ,WT.; Levy, RI.; Fredrickson,DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972;18(6):499-502.

Li Zhang, Ning Zhang, XinyuQuetal.Huaier extract exerts immunomodulatory effects by regulating serum cytokines in breast cancer.Vol 7, No 4 (August 2018).

Maximilian Boesch, Lucas Onder, Hung-Wei Cheng.Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. 07 Dec 2017, Published online: 03 Jan 2018.

M A A Al-Rawi et al.Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer. 2004 Mar.

JACK LIN, ZIWEN ZHU, HUAPING XIAO et al.The role of IL-7 in Immunity and Cancer Anticancer Research March 2017, 37 (3) 963-967.

Paul Zarogoulidis , Sofia Lampaki, Lonny Yarmus et al.Interleukin-7 and Interleukin-15 for Cancer.J Cancer 2014; 5(9):765-773. doi:10.7150/jca.10471.

Lithgow D, Covington C. Chronic inflammation and breast pathology: a theoretical model. Biological research for nursing. 2005;7(2):118-29.

Carpi A, Nicolini A, Antonelli A, Ferrari P, Rossi G. Cytokines in the management of high risk or advanced breast cancer: an update and expectation. Current Cancer Drug Targets. 2009;9(8):888-903.

Dmitrieva OS, Shilovskiy IP, Khaitov MR, Grivennikov SI: Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochem. 2016, 81:80-90. 10.1134/S0006297916020024.

Seema, M.. Lipid Profile in breast cancer patients. International Journal of Pharmaceutical and Medical Research(2015), 3(1):29-35.

FAGHERAZZI, Guy, et al. Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer. European Journal of Cancer Prevention, 2010, 19.2: 120-125

Alia'aSaadoon Abdul-Razaq Al-Faraji .(2011). Evaluation of Haptoglobin And Some Biochemical Parameters in Breast Cancer Patients At Different Cases'University of Baghdad College of Education Ibn-Al-Haitham .

Aziz Mahmood, A., Masood Bilal, K., &Talib Ibrahim, R. (2012). Influence ofsome Trace Elements and Biochemical Parameters on Breast Cancer. JOURNAL OF EDUCATION AND SCIENCE, 25(1), 34-43.

Al-Rubaye, F. G., Morad, T. S., Hamzah, M. I., & Hasan, S. M. (2015). Serum Lipid Profile in Iraqi patients with Breast Cancer. Journal of the Faculty of Medicine Baghdad, 57(4), 316-319.

Salman, W. A., &Najeeb, N. M. (2017). The physiological effect of breast canceron activity of aromatase enzyme and some concentrations of hormones and biochemical in the women in Baghdad city. Tikrit Journal of Pure Science, 22(5).

Alacacioglu, A., Kebapcilar, L., OnderPamuk, B., Sop, G., Kucukiravul, C., &Bozkaya, G. (2013). Oxidative and antioxidative status after anthracyclinebased chemotherapy in breast cancer patients. J BUON, 18(3), 614-8.

Alexopoulos, C. G., Blatsios, B., & Avgerinos, A. (1987). Serum lipids and lipoprotein disorders in cancer patients. Cancer, 60(12), 3065-3070.

Custódio, I. D. D., Marinho, E. D. C., Gontijo, C. A., Pereira, T. S. S., Paiva, C. E., & Maia, Y. C. D. P. (2016). Impact of chemotherapy on diet and nutritional statusof women with breast cancer: a prospective study. PLoS One, 11(6), e0157113.

Shah, F. D., Shukla, S. N., Shah, P. M., Patel, H. R., & Patel, P. S. (2008). Significance of alterations in plasma lipid profile levels in breast cancer. Integrative cancer therapies, 7(1), 33-41.

Sharma, M., Tuaine, J., McLaren, B., Waters, D. L., Black, K., Jones, L. M., &McCormick, S. P. (2016). Chemotherapy agents alter plasma lipids in breast cancerpatients and show differential effects on lipid metabolism genes in liver cells. PloS one, 11(1), e0148049.

Ali, L. O. (2014). Study effect of breast cancer on some hematological andbiochemical parameters in Babylon Province, Iraq. IOSR (IOSR-JPBS), 9(3), 20-24

Umesh, K. ;Ajeet, S. ; Bhadoria, N. and Sareen, P. (2013). Total Cholesterol and Triglyceride Levels in Patients with Breast Cancer. J Breast Cancer. 16(1): 129–130.

TIAN, Wei, et al. Changes in lipid profiles during and after (neo) adjuvant chemotherapy in women with early-stage breast cancer: A retrospective study. PLoS One, 2019, 14.8: e0221866

Eisenberg, S., Oschry, Y., & Zimmerman, J. (1984). Intravascular metabolism of the cholesteryl ester moiety of rat plasma lipoproteins. Journal of lipid research, 25(2), 121-128.

Willier S, Butt E, Grunewald TG. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Biol Cell (2013) 105:317–33. doi: 10.1111/boc.201300011.

Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA (2002) 287:3081–2. doi: 10.1001/jama.287.23.3081.

Atalay, G., Dirix, L., Biganzoli, L., Beex, L. V. A. M., Nooij, M., Cameron, D.&Paridaens, R. (2004). The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951,‘Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients’. Annals of oncology, 15(2), 211-217.

-WU, Jing, et al. Association between serum lipids and breast cancer risk in premenopausal women: systematic review and meta-analysis. Journal of International Medical Research, 2021, 49.11: 03000605211061033

KUMAR, Vipan, et al. A comparitive study to evaluate the role of serum lipid levels in aetiology of carcinoma breast. Journal of Clinical and Diagnostic Research: JCDR, 2015, 9.2: PC01

.AL-ATTAR, Huda Y. The Relegation of Female Hormones Level with Blood Lipids Concentration in Breast Tumors. Tikrit Journal of Pure Science, 2012, 17.1.

RAY, Gibanananda; HUSAIN, Syed A. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clinical biochemistry, 2001, 34.1: 71-76.